Enrichment Materials for Researchers and Clinical Scholars
Jones HE, et al. Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure. N Engl J Med. 2010.
Landmark RCT demonstrating buprenorphine results in less severe NOWS than methadone. Both are safe and effective for pregnant women with OUD.
Schiff DM, et al. Fatal and non-fatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol. 2018.
Demonstrated overdose risk peaks 7-12 months postpartum. Informed the AIM Patient Safety Bundle.
Grossman MR, et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics. 2017.
Demonstrated ~50% reduction in pharmacologic treatment with ESC approach compared to Finnegan-based care.
Preston KL, et al. Contingency management for stimulant use disorders: A systematic review. J Addict Med. 2020.
Confirmed CM as strongest evidence-based treatment for stimulant use disorder in pregnancy.
Three comprehensive cases (Maria/Keisha/Sarah) spanning ED → OB → Postpartum with teaching points.
15 ABPN-style questions with detailed rationales covering all major topics.
Workflows for warm handoffs, POSC templates, and ESC protocol implementation.
Handouts on MOUD in pregnancy, NOWS, breastfeeding on MOUD, and postpartum safety.